Emily Peterson, ’00, B.S., chemistry, completed her first total synthesis in organic chemistry with Professor James Vyvyan looking over her shoulder.
Today, Peterson is a director of Medicinal Chemistry at Novartis, leading the multinational pharmaceutical company’s search for new drugs to treat arrhythmia.
Previously, Peterson was a scientist and executive at Biogen, working and leading teams to synthesize molecules to treat multiple sclerosis, lupus and other diseases of the nervous and immune systems. As a scientist at Amgen, in addition to her role as a medicinal chemist, she led sustainability efforts and worked to reduce the amount of toxic dichloromethane used in the lab.
“I’m proud to say a compound I worked on at Biogen just started a Phase 1 trial in human,” Peterson says. “The timescale of drug discovery is very slow. Many medicinal chemists go their entire career never having a compound they worked on go forward to the clinic.”